The approval of Retevmo is for the treatment of advanced or metastatic medullary thyroid cancer with a RET mutation.

The following is a summary of “Use of Natural Language Processing to Extract and Classify Papillary Thyroid Cancer Features ...

Challenges and Opportunities,” published in the August 2024 issue of Endocrinology by Kotwal et al. This narrative review ...

Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes.

The incidence of salt sensitivity was found to be increased in untreated hypothyroid patients. A low-sodium diet induced small increases in plasma renin activity in hypothyroid patients with salt ...

Patients undergoing peritoneal dialysis (PD) have significantly higher thyroxine (T4) concentrations than hemodialysis (HD) ...

The FDA granted traditional approval to selpercatinib for the treatment of advanced or metastatic RET-mutated medullary ...

Geoffrey D. Young, MD, PhD, FACS, discussed the many advances in thyroid cancer management and treatment, highlighting what a ...

Graphic showing “How researchers used ‘multi-omics’ to discover potential drugs to repurpose for Hashimoto’s”.

As a child, EJ Beck was treated for a rare pediatric thyroid cancer at NYU Langone Health. About 10 years after the scan that ...

Thyroid cancer rates have been on the rise. Understanding risk factors and screening is key to early detection.

Patients with primary thyroid cancer who receive radioactive iodine therapy have an elevated risk for melanoma and other nonkeratinocyte skin cancers when limiting the cancer site to the head and neck ...